Virus News and Research

Latest Virus News and Research

Scientists are searching for the ‘perfect protein’ to develop mRNA-based malaria vaccine

After the success of mRNA vaccines against COVID-19, scientists are cautiously optimistic that the same technology can be used to tackle other widespread diseases such as malaria.

7 Apr 2022

SARS-CoV-2 mutations capable of widespread T-cell escape

A new study aimed to identify and screen the mutations observed in SARS-CoV-2 that help to facilitate CD8+ T-cell escape.

7 Apr 2022

SARS-CoV-2 detected using smartphone biosensor

Researchers describe the use of RT-LAMP in combination with particle diffusometry to detect SARS-CoV2 in saliva samples.

7 Apr 2022

COVID-19 could change the levels of proteins related to male reproductive function

Many people who recover from COVID-19 experience long-term symptoms, such as brain fog or heart problems. Increasing evidence suggests that the virus can also impair fertility.

7 Apr 2022

Researchers obtain a treasure trove of new data about RNA viruses from ocean water samples

Ocean water samples collected around the world have yielded a treasure trove of new data about RNA viruses, expanding ecological research possibilities and reshaping our understanding of how these small but significant submicroscopic particles evolved.

7 Apr 2022

Researchers reveal why people with allergic asthma are protected from severe COVID

The vast majority of people infected with the omicron variant of SARS-CoV-2 experience mild cold-like symptoms, moderate flu-like symptoms, or no symptoms at all, but the virus is so transmissible that it still spread deep into lung tissue to cause severe disease and death in thousands of people in the United States in 2022 alone.

7 Apr 2022

UGA researchers develop nanotechnology-based optical sensors for rapid coronavirus detection

A University of Georgia nanotechnology research group entered the race to develop a rapid test for COVID-19 in August 2020, running experiments on a new sensor for an American manufacturing company.

7 Apr 2022

Study investigates changing patterns of SARS-CoV-2 infection through Delta and Omicron waves

A new study examined whether SARS-CoV-2 infections in England varied by vaccination status, in cases with a previous COVID-19 positive test report individual, and by neighborhood socioeconomic deprivation, across the Delta and Omicron waves.

7 Apr 2022

Study explores broad-spectrum, host-acting antiviral strategy to treat SARS-CoV-2

A new study investigates the combination of two small molecules that target the host cells and reports a synergistic antiviral activity in vitro against SARS-CoV-2.

7 Apr 2022

Insights into the pathogenesis of the previous and circulating SARS-CoV-2 variants in mice

A recent article presented the diverse pathogenesis of SARS-CoV-2 variants of concern in a humanized mouse model.

7 Apr 2022

Study finds a significant reduction in the risk of COVID-19 infection among those who always wear glasses

Researchers analyzed the influence of the use of spectacles on COVID-19 risk in a community setting.

7 Apr 2022

A shortfall of ECMO treatment cost lives during the delta surge

Speaking from his hospital bed at Vanderbilt University Medical Center in Nashville, Tennessee, James Perkinson’s voice was raspy. In February, he’d just been taken off ECMO, the last-ditch life support treatment in which a machine outside the body does the work of the heart and lungs.

7 Apr 2022

Patient outcomes after influenza, RSV, or SARS-CoV-2 hospitalization

A recent study posted to the medRxiv* preprint server investigated the elements that predicted all-cause mortality among individuals hospitalized due to influenza, respiratory syncytial virus (RSV), or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

7 Apr 2022

SARS-CoV-2 spike S375F mutation triggered the explosive spread of Omicron

In a recent study posted to the bioRxiv* preprint server, researchers investigated the mutation in the viral spike (S) protein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.1 variant (referred to as Omicron in the present study) that is responsible for the variant’s virological features.

7 Apr 2022

COVID boosters protect you better than monoclonal antibodies, or natural infection

In a new study published in the journal Science Translational Medicine, researchers analyzed the neutralization of the Omicron BA.1 variant pseudovirus by post-vaccination serum samples.

6 Apr 2022

COVID-19 protection increases after fourth vaccine dose but declines quickly

A new study published in The New England Journal of Medicine has focussed on the relative effectiveness of the fourth dose, compared to the three doses vaccination regime, against confirmed infection and severe illness among older persons in the Israeli population.

6 Apr 2022

New platform for studying how the immune system responds to hepatitis C

A vaccine for hepatitis C has eluded scientists for more than 30 years, for several reasons. For one, the virus that causes the disease comes in many genetic forms, complicating the creation of a widely effective vaccine.

6 Apr 2022

Pandemic-era birth data reveals significant fall in cesarian, induced deliveries

Premature births from cesarian (C-sections) and induced deliveries fell by 6.5% during the first month of the Covid-19 pandemic and remained consistently lower throughout - a likely result of fewer prenatal visits due to efforts to slow the spread of the virus, according to new research from Georgia Tech's School of Economics.

6 Apr 2022

Study shows link between language status and health outcomes during COVID-19 hospitalizations

The language status of patients hospitalized for COVID-19 may significantly impact health outcomes during their admission, as non-English speaking individuals were found to have 35 percent greater odds of dying or requiring intensive care unit (ICU) support during the earliest phase of the pandemic compared to English-speaking patients, according to a study by Mass General Brigham (MGB).

6 Apr 2022

Study captures the immune effect of COVID-19 vaccine in patients with multiple myeloma

Most immunocompromised people with a blood cancer called multiple myeloma benefited from a third dose of COVID-19 vaccines, a promising sign after it was shown that two doses tended to not be sufficient for them.

6 Apr 2022

Virus News and Research

Latest Virus News and Research

Scientists are searching for the ‘perfect protein’ to develop mRNA-based malaria vaccine

SARS-CoV-2 mutations capable of widespread T-cell escape

SARS-CoV-2 detected using smartphone biosensor

COVID-19 could change the levels of proteins related to male reproductive function

Researchers obtain a treasure trove of new data about RNA viruses from ocean water samples

Researchers reveal why people with allergic asthma are protected from severe COVID

UGA researchers develop nanotechnology-based optical sensors for rapid coronavirus detection

Study investigates changing patterns of SARS-CoV-2 infection through Delta and Omicron waves

Study explores broad-spectrum, host-acting antiviral strategy to treat SARS-CoV-2

Insights into the pathogenesis of the previous and circulating SARS-CoV-2 variants in mice

Study finds a significant reduction in the risk of COVID-19 infection among those who always wear glasses

A shortfall of ECMO treatment cost lives during the delta surge

Patient outcomes after influenza, RSV, or SARS-CoV-2 hospitalization

SARS-CoV-2 spike S375F mutation triggered the explosive spread of Omicron

COVID boosters protect you better than monoclonal antibodies, or natural infection

COVID-19 protection increases after fourth vaccine dose but declines quickly

New platform for studying how the immune system responds to hepatitis C

Pandemic-era birth data reveals significant fall in cesarian, induced deliveries

Study shows link between language status and health outcomes during COVID-19 hospitalizations

Study captures the immune effect of COVID-19 vaccine in patients with multiple myeloma

A new way of characterising biomolecules eBook

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Newsletters you may be interested in